Latest news with #WELLHealthTechnologies
Yahoo
14-05-2025
- Business
- Yahoo
WELL Health Technologies (TSX:WELL) Reports CAD 46M Loss Despite 32% Revenue Growth
WELL Health Technologies reported a significant increase in Q1 2025 sales, though they also transitioned from a profit to a notable net loss. Over the past week, the company's stock rose 8.55%, a movement worth noting amidst a broader market rally of 5.3%. While WELL Health's substantial sales growth might have contributed positively, the net loss may have tempered excitement. Despite this, broader market trends led by tech sector gains, such as those in Nvidia and AMD, might have further buoyed investor sentiment towards WELL Health, aligning its performance with the general uptrend in the market. We've discovered 1 risk for WELL Health Technologies that you should be aware of before investing here. Outshine the giants: these 30 early-stage AI stocks could fund your retirement. The recent news surrounding WELL Health Technologies' transition from profit to a net loss, despite a reported increase in sales, could have implications for its future revenue and earnings trajectory. Although the stock rose 8.55% over the past week, aligning with a broader market rally, the company's five-year total shareholder return was 37.38%. This long-term performance offers a more tempered view compared to the single-year performance, where WELL Health underperformed the Canadian Healthcare industry, which returned 33%. In light of the recent developments, analysts' revenue growth projections for WELL Health could be influenced by the integration challenges of acquisitions and the impact of deferred revenues. With anticipated earnings of CA$47.4 million by 2028, there is pressure to enhance operational efficiencies to meet these expectations. Furthermore, the price movement towards the analyst consensus price target of CA$7.86, which stands at a notable premium over the current share price of CA$3.98, reflects investor optimism. Yet, this also highlights the need for the company to achieve substantial growth in both revenue and earnings to justify such a valuation. The announced initiatives, including strategic divestments and an anticipated IPO, could play a crucial role in altering WELL Health's financial landscape in the coming years. Navigate through the intricacies of WELL Health Technologies with our comprehensive balance sheet health report here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TSX:WELL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
11-05-2025
- Business
- Yahoo
1 Magnificent Healthcare Stock Down 46% to Buy and Hold Forever
Written by Adam Othman at The Motley Fool Canada Global stock markets have been incredibly volatile for several months, leaving plenty of new investors unsure of where to get the best returns with their capital right now. If you can look past the challenges of short-term market volatility and embrace a long-term view, there are plenty of high-quality opportunities waiting for your investment capital. The global landscape is changing across every sector of the economy, especially with the sudden rise in artificial intelligence (AI) technology advancements and adoption. AI is making improvements in every space, including the healthcare sector. The profound shift in healthcare technology, enabled by years of innovation and accelerated with AI technology, presents new and exciting growth opportunities for investors who can identify them. One such tech stock in the healthcare sector is WELL Health Technologies (TSX:WELL). The $983.91 million market-cap company is one of the businesses leading the charge in healthcare innovation, and it trades at a considerable discount from its all-time highs. Let's take a better look at the stock to see why it might be an excellent holding to add to your self-directed investment portfolio. WELL Health used to be a telehealth company that came into the limelight a few years ago during the pandemic. Social-distancing restrictions and health scares forced telemedicine adoption to speed up much faster than anticipated. Business boomed for WELL Health, as it provided better access to healthcare services to patients when they needed it the most from the safety of their homes. The company used the momentum well and made a series of aggressive acquisitions that have made it a comprehensive digital healthcare company. It is now Canada's largest owner and operator of outpatient health clinics, delivering healthcare-related services across Canada and the U.S. More recently, the company has started integrating AI technology into its range of services to improve the quality of patient care while streamlining operational efficiencies for healthcare providers. One of the best examples of its AI-powered innovations is WELL AI Voice, an assistant for healthcare providers that offers clinical documentation through natural language processing and voice recognition. Its WELL AI Decision Support offers important insights and recommendations to healthcare professionals by analyzing vast sets of patient data to help them make more efficient treatment plans and accurate diagnoses. Despite the decline in the need for telehealth services in the post-pandemic era, WELL Health is doing well as a business. The company had strong financials in fiscal 2024, reporting a 19% year-over-year growth in annual revenue, an almost 75% increase in net income, and a 16.3% uptick in free cash flow attributable to its investors. Looking ahead, the company has a positive outlook for fiscal 2025, with its projected revenue expected to be as high as $1.5 billion. As of this writing, WELL Health stock trades for $3.95 per share, down by over 46% from its 52-week high. If you are interested in investing in a high-growth space and have a well-balanced portfolio to help you ride the wave of any short-term market volatility, WELL Health stock can be an excellent pick to consider. The post 1 Magnificent Healthcare Stock Down 46% to Buy and Hold Forever appeared first on The Motley Fool Canada. Before you buy stock in WELL Health Technologies, consider this: The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and WELL Health Technologies wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $21,345.77!* Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*. See the Top Stocks * Returns as of 4/21/25 More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. 2025 Sign in to access your portfolio
Yahoo
22-04-2025
- Business
- Yahoo
Rainbows and Unicorns: WELL Health Technologies Corp. (TSE:WELL) Analysts Just Became A Lot More Optimistic
WELL Health Technologies Corp. (TSE:WELL) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The analysts greatly increased their revenue estimates, suggesting a stark improvement in business fundamentals. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Following the upgrade, the latest consensus from WELL Health Technologies' 13 analysts is for revenues of CA$1.4b in 2025, which would reflect a huge 49% improvement in sales compared to the last 12 months. Statutory earnings per share are supposed to decrease 7.2% to CA$0.12 in the same period. Prior to this update, the analysts had been forecasting revenues of CA$1.2b and earnings per share (EPS) of CA$0.069 in 2025. So we can see there's been a pretty clear increase in analyst sentiment in recent times, with both revenues and earnings per share receiving a decent lift in the latest estimates. View our latest analysis for WELL Health Technologies Despite these upgrades, the consensus price target fell 6.3% to CA$7.86, perhaps signalling that the uplift in performance is not expected to last. These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the WELL Health Technologies' past performance and to peers in the same industry. We can infer from the latest estimates that forecasts expect a continuation of WELL Health Technologies'historical trends, as the 49% annualised revenue growth to the end of 2025 is roughly in line with the 49% annual revenue growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 12% annually. So although WELL Health Technologies is expected to maintain its revenue growth rate, it's definitely expected to grow faster than the wider industry. The biggest takeaway for us from these new estimates is that analysts upgraded their earnings per share estimates, with improved earnings power expected for this year. Fortunately, analysts also upgraded their revenue estimates, and our data indicates sales are expected to perform better than the wider market. A lower price target is not intuitively what we would expect from a company whose business prospects are improving - at least judging by these forecasts - but if the underlying fundamentals are strong, WELL Health Technologies could be one for the watch list. Still, the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for WELL Health Technologies going out to 2027, and you can see them free on our platform here.. Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
15-04-2025
- Business
- Yahoo
WELL Health Technologies (TSX:WELL) Sees Revenue Surge With 2025 Guidance Reaching A$1.40 Billion
WELL Health Technologies recently provided robust earnings and revenue guidance, projecting revenue between CAD 1.40 billion and CAD 1.45 billion for 2025. Their reported sales of CAD 920 million in 2024, up from CAD 776 million, signifies healthy growth in the healthcare technology sector. This was reflected in a 2% price rise over the past week, which aligns with broader market trends where the market gained 7%. The positive financial outlook and earnings forecast likely complemented the overall market momentum, which has been supported by upward trends in tech stocks amid easing U.S.-China trade tensions. We've identified 2 risks with WELL Health Technologies (at least 1 which is a bit concerning) and understanding the impact should be part of your investment process. Uncover the next big thing with financially sound penny stocks that balance risk and reward. The recent robust earnings and revenue projections for WELL Health Technologies, forecasting CAD 1.40 billion to CAD 1.45 billion in revenue by 2025, could influence the company's strategic growth narrative, emphasizing consolidation and expansion within the healthcare technology sector. The anticipated revenue growth is likely to benefit from market momentum and easing trade tensions that have bolstered tech stocks. These optimistic forecasts may impact the company's earnings projections, despite analysts expecting a decline in profit margins to 3.1% from 7.7%. The company's emphasis on AI-driven tools and acquisitions could streamline operations, further supporting revenue growth but potentially causing profit margins to decline over time. Over the past five years, WELL Health Technologies has delivered a total shareholder return of 125.93%, reflecting significant long-term value creation. This return contrasts with the company's one-year performance, where it exceeded both the Canadian Market, up 7.4%, and the healthcare industry, which saw a 20.5% gain. The current share price of CAD 4.00 presents a substantial discount to the analyst consensus price target of CAD 8.39, suggesting a more than 50% potential upside if market conditions align with the analysts' expectations. Investors may need to consider how these projections align with their own analyses, especially given the expected decline in earnings growth over the next three years. Examine WELL Health Technologies' earnings growth report to understand how analysts expect it to perform. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TSX:WELL. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
